484 related articles for article (PubMed ID: 34518209)
1. WNT as a Driver and Dependency in Cancer.
Parsons MJ; Tammela T; Dow LE
Cancer Discov; 2021 Oct; 11(10):2413-2429. PubMed ID: 34518209
[TBL] [Abstract][Full Text] [Related]
2. Metabolic balance in colorectal cancer is maintained by optimal Wnt signaling levels.
Imkeller K; Ambrosi G; Klemm N; Claveras Cabezudo A; Henkel L; Huber W; Boutros M
Mol Syst Biol; 2022 Aug; 18(8):e10874. PubMed ID: 35904277
[TBL] [Abstract][Full Text] [Related]
3. The Roles of Secreted Wnt Ligands in Cancer.
Werner J; Boonekamp KE; Zhan T; Boutros M
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982422
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling pathway in cancer immunotherapy.
Zhou Y; Xu J; Luo H; Meng X; Chen M; Zhu D
Cancer Lett; 2022 Jan; 525():84-96. PubMed ID: 34740608
[TBL] [Abstract][Full Text] [Related]
5. Wnt Signaling and Drug Resistance in Cancer.
Zhong Z; Virshup DM
Mol Pharmacol; 2020 Feb; 97(2):72-89. PubMed ID: 31787618
[TBL] [Abstract][Full Text] [Related]
6. Lineage Reversion Drives WNT Independence in Intestinal Cancer.
Han T; Goswami S; Hu Y; Tang F; Zafra MP; Murphy C; Cao Z; Poirier JT; Khurana E; Elemento O; Hechtman JF; Ganesh K; Yaeger R; Dow LE
Cancer Discov; 2020 Oct; 10(10):1590-1609. PubMed ID: 32546576
[TBL] [Abstract][Full Text] [Related]
7. Wnt Signaling in the Tumor Microenvironment.
Ruan Y; Ogana H; Gang E; Kim HN; Kim YM
Adv Exp Med Biol; 2021; 1270():107-121. PubMed ID: 33123996
[TBL] [Abstract][Full Text] [Related]
8. Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights.
Patel S; Alam A; Pant R; Chattopadhyay S
Front Immunol; 2019; 10():2872. PubMed ID: 31921137
[TBL] [Abstract][Full Text] [Related]
9. Wnt Pathway: An Integral Hub for Developmental and Oncogenic Signaling Networks.
Sharma M; Pruitt K
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126517
[TBL] [Abstract][Full Text] [Related]
10. The Wnt signaling pathway in cancer.
Duchartre Y; Kim YM; Kahn M
Crit Rev Oncol Hematol; 2016 Mar; 99():141-9. PubMed ID: 26775730
[TBL] [Abstract][Full Text] [Related]
11. The Role of Wnt Signaling in Squamous Cell Carcinoma.
Shiah SG; Shieh YS; Chang JY
J Dent Res; 2016 Feb; 95(2):129-34. PubMed ID: 26516128
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic alterations of the Wnt signaling pathway in cancer: a mini review.
Serman L; Nikuseva Martic T; Serman A; Vranic S
Bosn J Basic Med Sci; 2014 Nov; 14(4):191-4. PubMed ID: 25428669
[TBL] [Abstract][Full Text] [Related]
13. A New Wave of Targeting 'Undruggable' Wnt Signaling for Cancer Therapy: Challenges and Opportunities.
Park WJ; Kim MJ
Cells; 2023 Apr; 12(8):. PubMed ID: 37190019
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing within the Wnt signaling pathway: role in cancer development.
Sumithra B; Saxena U; Das AB
Cell Oncol (Dordr); 2016 Feb; 39(1):1-13. PubMed ID: 26762488
[TBL] [Abstract][Full Text] [Related]
15. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
Katoh M
Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
[TBL] [Abstract][Full Text] [Related]
16. Targeting Oncogenic WNT Signalling with WNT Signalling-Derived Peptides.
Yadav V; Jobe N; Mehdawi L; Andersson T
Handb Exp Pharmacol; 2021; 269():279-303. PubMed ID: 34455485
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between long non-coding RNAs and Wnt/β-catenin signalling in cancer.
Yang G; Shen T; Yi X; Zhang Z; Tang C; Wang L; Zhou Y; Zhou W
J Cell Mol Med; 2018 Apr; 22(4):2062-2070. PubMed ID: 29392884
[TBL] [Abstract][Full Text] [Related]
18. Wnt/β-Catenin Signaling Pathway in Skin Carcinogenesis and Therapy.
Li J; Ji L; Chen J; Zhang W; Ye Z
Biomed Res Int; 2015; 2015():964842. PubMed ID: 26078973
[TBL] [Abstract][Full Text] [Related]
19. WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment.
Li X; Xiang Y; Li F; Yin C; Li B; Ke X
Front Immunol; 2019; 10():2293. PubMed ID: 31616443
[TBL] [Abstract][Full Text] [Related]
20. Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/β-catenin signaling.
Ahmad R; Kumar B; Chen Z; Chen X; Müller D; Lele SM; Washington MK; Batra SK; Dhawan P; Singh AB
Oncogene; 2017 Nov; 36(47):6592-6604. PubMed ID: 28783170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
